Italy has observed a 58.95 million (4.9%) increase in the research & development by business enterprise, pharmaceutical industry in current ppp $, which now stands at 1,252.12 million.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Italy
No matching regions
Similar regions to Italy
Business R&D pharmaceutical in current PPP $
More indicators for Italy
Government R&D in security as % of government support
0.51%
+0.07%
(2021)
Higher-education-finacing R&D financed by general university in local currency
41,060.76M
+1,583.99M
(2021)
R&D financed by rest of the world in local currency
22,883.16M
-5,358.99M
(2021)
Government R&D financed by rest of the world in local currency
2,372.94M
-83.30M
(2021)
Business R&D financed by rest of the world in local currency
14,853.07M
-5,054.20M
(2021)
Non-profit R&D growth rate
0.64%
-0.01%
(2022)
Italy Business R&D pharmaceutical in current PPP $ between 1991 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 1,252.12M | +58.95M |
| 2020 | 1,193.17M | +179.20M |
| 2019 | 1,013.98M | +118.57M |
| 2018 | 895.41M | +26.93M |
| 2017 | 868.47M | +26.76M |
| 2016 | 841.72M | +112.32M |
| 2015 | 729.40M | +37.68M |
| 2014 | 691.71M | -46.52M |
| 2013 | 738.23M | -33.30M |
| 2012 | 771.53M | +9.16M |
| 2011 | 762.37M | +41.79M |
| 2010 | 720.58M | +28.93M |
| 2009 | 691.65M | +79.04M |
| 2008 | 612.61M | +91.72M |
| 2007 | 520.89M | +107.80M |
| 2006 | 413.09M | -39.15M |
| 2005 | 452.24M | +25.48M |
| 2004 | 426.76M | -146.91M |
| 2003 | 573.67M | -10.74M |
| 2002 | 584.41M | -42.95M |
| 2001 | 627.36M | -11.90M |
| 2000 | 639.27M | +31.56M |
| 1999 | 607.71M | -6.72M |
| 1998 | 614.43M | +58.17M |
| 1997 | 556.26M | -22.94M |
| 1996 | 579.20M | -27.16M |
| 1995 | 606.36M | -12.19M |
| 1994 | 618.55M | -64.19M |
| 1993 | 682.74M | -101.08M |
| 1992 | 783.81M | +18.82M |
| 1991 | 765.00M |